Also found in: Acronyms.
ADEPAtherosclerotic Disease Evolution by Picotamide Study. A trial that studied the safety and efficacy of platelet picotamide, an inhibitor of thromboxane A2 (TxA2) synthase and TxA2 receptor antagonist, in reducing the complications of peripheral vascular disease.
Conclusion Unimpressive borderline statistical difference between the 2 groups vis-à-vis major and minor events. Picotamide has not been widely developed.